02 Certification of Performance Sharing Companies

03 RCI001 MFDS Phase 1 IND  Approval

01 Licensed-out RCI001U to Hanlim pharmaceutical Co.

02 A novel peptide and sue therof Patent Application

03 Signed MOU with ONHEAL, ONHEALPET for joint development of veterinary drugs

       Attend Bio-Europe Spring(Basel, Switzerland)

05 2023 Certification of Small Giant Corporate by the Ministry of Employment and Labor

       Signed MOU with Darae Biz for consulting about Special Listed Technology Growth IPO

       Attracted investment from Darae individaul investment association

06 Attend 2023 ASCO(Americna Society of Clinical Incology, Chicago)

       Attend BIO-USA 2023(Boston) 

       Selected Incheon Startup Park Boost Startup Program

07 Attend Inter-Biz 2023

       Certification of Performance Sharing Companies

09 Attend the University of Utah Global Startup Outreach Program

       RCI001 Eye drop formulation Patent Application 

10 Attend Global Innovation Roadshow(Singapore) 

       Selected SBA TIPS Program

11 Won KICDC/Defy Pitch Competition 1st Prize 

       Attend Bio Europe Fall 2023(Munchen, Germany) 

       Attend ACR(American College of Reumatology) Convergence 2023(San Diego, USA)

       RCI001 formulation PCT application

       RCI001 derivative patent applicaiton

12 Hanllym Univ. - EIONCELL CAR-T and ADC joint research

       Attracted investment from C&R Research, DreamCIS 

01 Selected BIG3 Innovation Startup Package by the Ministry of SMEs and Startups

03 Certification of Inno-Biz

04 Selected to be a 2022 regular membership(Global) of Shinhan Square Bridge Incheon

05 Attracted investment from Korea Venture Fund

       Certification of Small Giant Corporate by the Ministry of Employment and Labor

       Selected Smart-X Bio Hanlim pharmaceutical Co. Program

06 Certification of Performance Sharing Companies

       RCI002 China Patent Application 

       Attend BIO-USA (San Diego) 

07 Headquaters relocation(BRC) and open Seoul office

       RCI002 Japan Patent Application 

08 Selected to be a cooperation company of  Korea Drug Development Fund

       Attend UKC 2022 (Washington D.C.) and won Start-up IR Competition SBA Award

09 Attend RESI Conference (Boston) and won RESI Innovato's challenge 3rd prize

10 Remodeling HQ office in Incheon

11 Attend Tech Summit (Washington D.C.)

01 Headquarters relocation (Incheon Startup Park)

04 Licensed-out RCI001 to Hanlim pharmaceutical Co. for domestic rights 

07 RCI002 PCT and US Patent Application

08 RudaCure U.S.A. Establishment of U.S. Corporate

09 Selected to be part of Bio I-Corps Program by the Minister of Science & Technology

       Attracted investments from Y&Archer and other individual investors

10 Two trademark registrations

11 Venture Investment Association (CKD Startup Investment) to attract investment

12 RCI002 Domestic Patent Registration
       Atopic dermatitis/AMD before extension of applicability
       Full-time Toxicity and Effectiveness Test Research Service Expansion

01 Accreditation of the Institute of Corporate Affiliated Research Institut

03 Agreement on Small and Medium Venture Performance Sharing Companies

05 Certification of Venture Businesses

11 Attract investment in technology guarantee

12 Headquarters Extension

07.23 Establishment of Rudacure co., ltd.